News – Page 645 – Endpoints News

Moderna surfaces as the first partner for Jim Wilson's rare disease nonprofit, donating an mRNA program at no cost

4 years ago

As bluebird plans its big split, rare disease head Andrew Obenshain recruits Ironwood vet as CFO

4 years ago

'Like a kid in a candy shop': Michael Ehlers gets behind RNA 'copy machine' tech

4 years ago

With industry's blessing, FDA launches novel excipient review pilot program

4 years ago

Sanofi picks up Kadmon and its transplant drug in $1.9B buyout, giving Sam Waksal 2 Big Pharma buyouts under his belt

4 years ago

Merck KGaA entrusts secretive startup with a mid-stage cancer drug targeting master signaling pathway

4 years ago

Years after Pfizer passed on a buyout option, AM-Pharma finds a new partner for its kidney drug

4 years ago

MacroGenics flips over an OS dud for cancer drug Margenza in surprising turnaround from earlier data

4 years ago

UK unions lambast plan for major layoffs at MHRA as Brexit takes its toll

4 years ago

There's a new anti-aging upstart in town — and it's reportedly backed by Amazon billionaire Jeff Bezos

4 years ago

Food or drug? FDA blasts Flagship-backed microbiome player’s ‘non-IND’ Covid-19 trial

4 years ago

Moving on from a major setback, Roche lines up a new Huntington's program for gene therapy sub Spark

4 years ago

Doubling down on need for mRNA vaccines and mAbs, Avantor puts nearly $3B in pumps and tubing company

4 years ago

Vaccitech makes short move to new headquarters; EnteroBiotix raises more than $21M in Series A

4 years ago

As tezepelumab awaits FDA decision, Amgen and AstraZeneca tout more data from the Phase III study

4 years ago

GSK, J&J and Pfizer vie for $10B RSV vaccine market, with Bavarian Nordic and Moderna hot on their trail

4 years ago

Cancer giant Roche splashes into cell therapy with $3B+ Adaptimmune deal for off-the-shelf drugs

4 years ago

Liver tumors in animals trigger clinical hold for BioMarin gene therapy — highlighting a recurring concern

4 years ago

Exelixis mourns the deaths of two longtime executives

4 years ago

Covid-19 roundup: Brazil holds Sinovac doses after manufacturing mix up; Takeda to produce Novavax vaccine

4 years ago

'A missed opportunity': The biggest takeaways from the FDA's underwhelming gene therapy hearing

4 years ago

White House seeks $65B to prepare for future pandemics in 'Apollo'-like effort

4 years ago

Two Feng Zhang lab alumni find a new CRISPR enzyme that could take a Big Gulp out of RNA — and a raft of ...

4 years ago

Abrupt FDA exits spark concern; Unpacking key concepts at gene therapy summit; 20 luminaries who reshaped R&D; and ...

4 years ago

First page Previous page 642 643 644645646 647 648 Next page Last page